Literature DB >> 3527829

Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus.

R R Henry, P Wallace, J M Olefsky.   

Abstract

To quantitate the effects of weight loss on the mechanisms responsible for hyperglycemia in non-insulin-dependent diabetes mellitus (NIDDM), eight obese subjects with NIDDM were studied before and after weight reduction with posttreatment assessment after 3 wks of isocaloric (weight maintenance) refeeding. After weight loss of 16.8 +/- 2.7 kg (mean +/- SE), the fasting plasma glucose level decreased 55% from 277 +/- 21 to 123 +/- 8 mg/dl. The individual fasting glucose levels were highly correlated with the elevated basal rates of hepatic glucose output (HGO) (r = 0.91, P less than .001), which fell from 138 +/- 11 to 87 +/- 5 mg X m-2 X min-1 after weight loss. The change in fasting plasma glucose also correlated significantly with the change in the basal rates of HGO (r = 0.74, P less than .05). This was associated with reduced fasting serum levels of glucagon (from 229 +/- 15 to 141 +/- 12 pg/ml), reduced free fatty acids (from 791 +/- 87 to 379 +/- 35 mu eq/L), and unchanged basal insulin levels (17 +/- 4 to 15 +/- 2 microU/ml).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527829     DOI: 10.2337/diab.35.9.990

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

Review 1.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 2.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

3.  Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression.

Authors:  F J Ortega; J M Moreno-Navarrete; D Mayas; M Serino; J I Rodriguez-Hermosa; W Ricart; E Luche; R Burcelin; F J Tinahones; G Frühbeck; G Mingrone; J M Fernández-Real
Journal:  Int J Obes (Lond)       Date:  2013-09-03       Impact factor: 5.095

4.  In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.

Authors:  G R Freidenberg; S L Suter; R R Henry; D Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 5.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 6.  Calorie restriction for long-term remission of type 2 diabetes.

Authors:  Roy Taylor
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

7.  Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery.

Authors:  Mousumi Bose; Julio Teixeira; Blanca Olivan; Baani Bawa; Sara Arias; Sriram Machineni; F Xavier Pi-Sunyer; Philipp E Scherer; Blandine Laferrère
Journal:  J Diabetes       Date:  2010-03       Impact factor: 4.006

Review 8.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 9.  Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Authors:  Mousumi Bose; Blanca Oliván; Julio Teixeira; F Xavier Pi-Sunyer; Blandine Laferrère
Journal:  Obes Surg       Date:  2008-09-27       Impact factor: 4.129

10.  Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes.

Authors:  Jeanine B Albu; Leonie K Heilbronn; David E Kelley; Steven R Smith; Koichiro Azuma; Evan S Berk; F Xavier Pi-Sunyer; Eric Ravussin
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.